Why is Kobo Biotech falling/rising?

As of 27-Jun, Kobo Biotech Ltd's stock price is currently at Rs. 2.35, reflecting a decrease of Rs. 0.07 or 2.89%. The stock has hit a new 52-week low of Rs. 2.32 today and has been on a downward trend, having fallen consecutively for the last two days, resulting in a total decline of 6.37%. Over the past week, the stock has underperformed significantly, with a return of -4.08%, while the benchmark Sensex has gained 2.00%. Additionally, the company's long-term fundamentals appear weak, as it has not declared results in the last six months, and its net sales have shown a drastic annual decline of 100%. The stock's performance has been further hindered by a high debt-to-equity ratio and poor quarterly results, which have contributed to its classification as a strong sell.
In the broader market context, Kobo Biotech's recent performance contrasts sharply with the Sensex, which has shown positive returns across various time frames, including a 3.07% increase over the past month and a 7.58% gain year-to-date. The stock's liquidity has also decreased, with a significant drop in delivery volume, indicating reduced investor interest. Overall, the combination of poor financial results, negative growth trends, and a lack of investor participation has led to the stock's decline, making it less attractive compared to the broader market performance.